Search Results - "Pankert, Mathieu"

A new approach: Left atrial appendage occlusion, as an alternative to anticoagulant, to treat patient who suffered of atrial fibrillation, acute coronary syndrome and clopidogrel resistance.

Authors: Pankert, Mathieu Salaun, Erwan Cuisset, Thomas et al.

Source: International Journal of Cardiology. Jan2016, Vol. 202, p900-903. 4p.

Impact of Obesity and the Metabolic Syndrome on Response to Clopidogrel or Prasugrel and Bleeding Risk in Patients Treated After Coronary Stenting.

Authors: Pankert, Mathieu Quilici, Jacques Loundou, Anderson Diendonné et al.

Source: American Journal of Cardiology. 2014, Vol. 113 Issue 1, p54-59. 6p.

Chronic kidney disease has a significant impact on platelet inhibition of new P2Y12 inhibitors.

Authors: Deharo, Pierre Pankert, Mathieu Quilici, Jacques et al.

Source: International Journal of Cardiology. Apr2015, Vol. 184, p428-430. 3p.

Body mass index has no impact on platelet inhibition induced by ticagrelor after acute coronary syndrome, conversely to prasugrel.

Authors: Deharo, Pierre Pankert, Mathieu Bonnet, Guillaume et al.

Source: International Journal of Cardiology. Oct2014, Vol. 176 Issue 3, p1200-1202. 3p.

Great expectations.

Authors: Lemesle, Gilles Laine, Marc Pankert, Mathieu et al.

Source: Lancet. 1/27/2018, Vol. 391 Issue 10118, p306-306. 1p.

Subjects: Acute coronary syndrome, Clinical trials, Treatment of acute coronary syndrome, Time, Treatment effectiveness

Unusual cause of hypoxemia in myocardial infarction: Interventional management.

Authors: Pankert, Mathieu Cuisset, Thomas Aldebert, Philippe et al.

Source: International Journal of Cardiology. Apr2014, Vol. 172 Issue 3, pe436-e437. 0p.

Rupture colmatée d'un anévrisme de valsalva d'évolution favorable après chirurgie.

Authors: Aboukhoudir, F. Jaussaud, N. Rekik, Sofiéne et al.

Source: Annales de Cardiologie et d'Angéiologie. Nov2021, Vol. 70 Issue 5, p360-366. 7p.

Femoral Versus Nonfemoral Peripheral Access for Transcatheter Aortic Valve Replacement.

Authors: Beurtheret, Sylvain Karam, Nicole Resseguier, Noemie et al.

Source: Journal of the American College of Cardiology (JACC). Dec2019, Vol. 74 Issue 22, p2728-2739. 12p.

Effectiveness of switching 'low responders' to prasugrel to ticagrelor after acute coronary syndrome.

Authors: Bassez, Clémence Deharo, Pierre Pankert, Mathieu et al.

Source: International Journal of Cardiology. Oct2014, Vol. 176 Issue 3, p1184-1185. 2p.

Coronarographie et angioplastie coronaire ambulatoire ; pourquoi, comment, pour quels patients ?

Authors: Quillot, Marine Lasserre, Raphaël Moussa, Karim et al.

Source: Annales de Cardiologie et d'Angéiologie. Nov2024, Vol. 73 Issue 5, pN.PAG-N.PAG. 1p.

Effectiveness of switching ‘hyper responders’ from Prasugrel to Clopidogrel after acute coronary syndrome: The POBA (Predictor of Bleeding with Antiplatelet drugs) SWITCH study.

Authors: Deharo, Pierre Pons, Coline Pankert, Mathieu et al.

Source: International Journal of Cardiology. Oct2013, Vol. 168 Issue 5, p5004-5005. 2p.

Usefulness of Index of Microcirculatory Resistance to detect microvascular dysfunction as a potential mechanism of stress-induced cardiomyopathy (tako-tsubo syndrome)

Authors: Cuisset, Thomas Quilici, Jacques Pankert, Mathieu et al.

Source: International Journal of Cardiology. Dec2011, Vol. 153 Issue 3, pe51-e53. 0p.

Effect of CYP2C19*2 and *17 Genetic Variants on Platelet Response to Clopidogrel and Prasugrel Maintenance Dose and Relation to Bleeding Complications.

Authors: Grosdidier, Charlotte Quilici, Jacques Loosveld, Marie et al.

Source: American Journal of Cardiology. 2013, Vol. 111 Issue 7, p985-990. 6p.

Comparison of Platelet Reactivity and Clopidogrel Response in Patients ≤75 Years Versus >75 Years Undergoing Percutaneous Coronary Intervention for Non–ST-Segment Elevation Acute Coronary Syndrome

Authors: Cuisset, Thomas Quilici, Jacques Grosdidier, Charlotte et al.

Source: American Journal of Cardiology. Nov2011, Vol. 108 Issue 10, p1411-1416. 6p.

Usefulness of High Clopidogrel Maintenance Dose According to CYP2C19 Genotypes in Clopidogrel Low Responders Undergoing Coronary Stenting for Non ST Elevation Acute Coronary Syndrome

Authors: Cuisset, Thomas Quilici, Jacques Cohen, William et al.

Source: American Journal of Cardiology. Sep2011, Vol. 108 Issue 6, p760-765. 6p.

Thrombose extensive intracardiaque dans un contexte de coagulation intravasculaire disséminée.

Authors: Aboukhoudir, Falah Veyrier, Jason Dernys, Alexandra et al.

Source: Annales de Cardiologie et d'Angéiologie. Nov2023, Vol. 72 Issue 5, pN.PAG-N.PAG. 1p.

Off-label use of prasugrel in stable coronary artery disease is associated with greater degree of platelet inhibition compared with use after acute coronary syndrome.

Authors: Cuisset, Thomas Cayla, Guillaume Quilici, Jacques et al.

Source: International Journal of Cardiology. Oct2013, Vol. 168 Issue 3, p2988-2989. 2p.

OUTCOMES AFTER TRANSTHORACIC, PERIPHERAL VASCULAR AND TRANSFEMORAL TRANSCATHETER AORTIC VALVE IMPLANTATION: A PROPENSITY ANALYSIS FROM FRANCE TAVI REGISTRY.

Authors: Beurtheret, Sylvain Karam, Nicole Resseguier, Noemie et al.

Source: Journal of the American College of Cardiology (JACC). Mar2018 Supplement, Vol. 71, pA990-A990. 1p.

Fixed-dose aspirin–clopidogrel combination enhances compliance to aspirin after acute coronary syndrome.

Authors: Deharo, Pierre Quilici, Jacques Bonnet, Guillaume et al.

Source: International Journal of Cardiology. Mar2014, Vol. 172 Issue 1, pe1-e2. 0p.

Prasugrel versus ticagrelor in acute coronary syndrome: A randomized comparison.

Authors: Deharo, Pierre Bassez, Clemence Bonnet, Guillaume et al.

Source: International Journal of Cardiology. Dec2013, Vol. 170 Issue 2, pe21-e22. 0p.